FDA Approves First Gene Therapy Treatment for Sanfilippo Syndrome Type A, Developed at the Abigail Wexner Research Institute at Nationwide Children's Hospital
September 22, 2026
September 22, 2026
COLUMBUS, Ohio, Sept. 22 [Category: BizHealth Care] -- Nationwide Children's Hospital posted the following news release:
* * *
FDA Approves First Gene Therapy Treatment for Sanfilippo Syndrome Type A, Developed at the Abigail Wexner Research Institute at Nationwide Children's Hospital
*
(COLUMBUS, Ohio) - Today, the Abigail Wexner Research Institute at Nationwide Children's Hospital celebrated the Food and Drug Administration . . .
* * *
FDA Approves First Gene Therapy Treatment for Sanfilippo Syndrome Type A, Developed at the Abigail Wexner Research Institute at Nationwide Children's Hospital
*
(COLUMBUS, Ohio) - Today, the Abigail Wexner Research Institute at Nationwide Children's Hospital celebrated the Food and Drug Administration . . .